Debaleena Nawn

Dr. Debaleena Nawn


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Alaa A. A. AljabaliAlaa A. A. Aljabali
Alaa A. A. Aljabali
MOMohammad Obeid
Mohammad Obeid
OGOmar Gammoh
Omar Gammoh
Mohamed El-TananiMohamed El-Tanani
Mohamed El-Tanani
VMVijay Mishra
Vijay Mishra
Murtaza TambuwalaMurtaza Tambuwala
Murtaza Tambuwala
Immunotherapy is a rapidly advancing field of research in the treatment of conditions such as cancer and autoimmunity. Nanomaterials can be designed for immune system manipulation, with precise targeted delivery and improved immunomodulatory efficacy. Here, we elaborate on various strategies using nanomaterials, including liposomes, polymers, and inorganic NPs, and discuss their detailed design intricacies, mechanisms, and applications, including the current regulatory issues. This type of nanomaterial design for targeting specific immune cells or tissues and controlling release kinetics could push current technological frontiers and provide new and innovative solutions for immune-related disorders and diseases without off-target effects. These materials enable targeted interactions with immune cells, thereby enhancing the effectiveness of checkpoint inhibitors, cancer vaccines, and adoptive cell therapies. Moreover, they allow for fine-tuning of immune responses while minimizing side effects. At the intersection of nanotechnology and immunology, nanomaterial-based platforms have immense potential to revolutionize patient-centered immunotherapy and reshape disease management. By prioritizing safety, customization, and compliance with regulatory standards, these systems can make significant contributions to precision medicine, thereby significantly impacting the healthcare landscape.

21 January 2021 in IEEE Sensors Journal
Verified
Journal Article
Closed access
NSNeha Sharma
Neha Sharma
DNDebaleena Nawn
Debaleena Nawn
SPSawon Pratiher
Sawon Pratiher
SSSayani Shome
Sayani Shome
RCRitam Chatterjee
Ritam Chatterjee
JCJyotirmoy Chatterjee
Jyotirmoy Chatterjee
Saliva has emerged as an efficient screening sample for early stage detection of oral cancer (OC) owing to non-invasiveness coupled with high sensitivity and specificity. Although spectroscopic characterization of saliva in oral potentially malignant disorders OPMDs) and OC is extensively studied, its potential as imaging biomarker is sparsely explored. Further, the literature on crystalline pattern of saliva for other diseases or different physiological conditions is mostly qualitative. This paper proposed multifractal based methodology to quantitatively study alteration of the salivary fern pattern in different OPMDs and OC in relation to normal counterpart. The fern pattern of dried saliva is captured by stereo-zoom microscope in reflective mode and an image dataset is developed. We resort to two dimensional multi-fractal detrended fluctuation analysis (2d MFDFA) to elucidate the complexity and heterogeneity of these micro-structured patterns. Existence of multifractal nature embedded in salivary fern has been validated for the first time. Long range spatial correlation is found to be the origin of multifractality. Variation in multi-scale self-similarity of irregular pattern in different study groups is demonstrated by four features extracted from MFDFA. Statistical analysis shows discriminating nature of these features for combinations of pairwise interclass classification. This study sheds light on acceptability of microscopic images of arborized saliva in fast and cost effective screening of different oral lesions.

26 May 2020 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DNDebaleena Nawn
Debaleena Nawn
SPSawon Pratiher
Sawon Pratiher
SCSubhankar Chattoraj
Subhankar Chattoraj
DCDebjani Chakraborty
Debjani Chakraborty
MPMousumi Pal
Mousumi Pal
JCJyotirmoy Chatterjee
Jyotirmoy Chatterjee
Bright-field microscopy (BFM) encrypts the optical transillumination profile of the transmitted light attenuated by the complex micro-structural tissue convolutions, manifested by the dense and compact regions of the specimen under examination. The connotations of idiosyncratic tissue interaction dynamics with the onset of pre-cancerous activity are encoded in the BFM acquired oral mucosa histopathological images (OMHI). In the present study, our analysis is focused on the sub-epithelium region of the oral mucosa, which has high clinical significance but sparsely explored in the literature from the textural domain. Histopathology being the gold-standard technique till date, we have used the light microscopic histopathology images for tissue characterization. The tissue-index transmission patches (TITP) from the sub-epithelium region are cropped under the guidance of oral onco-pathologists. After that, the TITPs are characterized for its multi-scale spatial-deformation dynamics, while keeping the intrinsic anisotropic geometry, and local contour connectivity within tolerable limits. With recent studies exhibiting multifractal's potency in diverse biological system analysis, here, we exploit the 2D multifractal detrended fluctuation analysis (2D-MFDFA) on TITPs for exploring a discriminative set of multifractal signatures for healthy, oral potentially malignant disorders and oral cancer tissue sample. The predictive model's competency is validated on an experimentally collected corpus of TITP samples and substantiated via confirmatory data statistics and analysis, showing its inter-class segregation efficacy. Moreover, the 2D MFDFA analysis evinces the complex multifractal patterns in TITPs, which is due to the presence of composite long-range correlations in the oral mucosa tissue fabric.

15 July 2025 in Viruses
Verified
Journal Article
Open access
PDF file
Alaa A. A. AljabaliAlaa A. A. Aljabali
Alaa A. A. Aljabali
Kenneth LundstromKenneth Lundstrom
Kenneth Lundstrom
Altijana Hromic-JahjefendicAltijana Hromic-Jahjefendic
Altijana Hromic-Jahjefendic
Nawal Abd EL-BakyNawal Abd EL-Baky
Nawal Abd EL-Baky
DNDebaleena Nawn
Debaleena Nawn
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
Narrative review synthesizes the most current literature on the SARS-CoV-2 XEC variant, focusing on its genomic evolution, immune evasion characteristics, epidemiological dynamics, and public health implications. To achieve this, we conducted a structured search of the literature of peer-reviewed articles, preprints, and official surveillance data from 2023 to early 2025, prioritizing virological, clinical, and immunological reports related to XEC and its parent lineages. Defined by the distinctive spike protein mutations, T22N and Q493E, XEC exhibits modest reductions in neutralization in vitro, although current evidence suggests that mRNA booster vaccines, including those targeting JN.1 and KP.2, retain cross-protective efficacy against symptomatic and severe disease. The XEC strain of SARS-CoV-2 has drawn particular attention due to its increasing prevalence in multiple regions and its potential to displace other Omicron subvariants, although direct evidence of enhanced replicative fitness is currently lacking. Preliminary analyses also indicated that glycosylation changes at the N-terminal domain enhance infectivity and immunological evasion, which is expected to underpin the increasing prevalence of XEC. The XEC variant, while still emerging, is marked by a unique recombination pattern and a set of spike protein mutations (T22N and Q493E) that collectively demonstrate increased immune evasion potential and epidemiological expansion across Europe and North America. Current evidence does not conclusively associate XEC with greater disease severity, although additional research is required to determine its clinical relevance. Key knowledge gaps include the precise role of recombination events in XEC evolution and the duration of cross-protective T-cell responses. New research priorities include genomic surveillance in undersampled regions, updated vaccine formulations against novel spike epitopes, and long-term longitudinal studies to monitor post-acute sequelae. These efforts can be augmented by computational modeling and the One Health approach, which combines human and veterinary sciences. Recent computational findings (GISAID, 2024) point to the potential of XEC for further mutations in under-surveilled reservoirs, enhancing containment challenges and risks. Addressing the potential risks associated with the XEC variant is expected to benefit from interdisciplinary coordination, particularly in regions where genomic surveillance indicates a measurable increase in prevalence.

16 January 2024 in Computers in Biology and Medicine
Verified
Journal Article
Open access
Sk Sarif HassanSk Sarif Hassan
Sk Sarif Hassan
TBTanishta Bhattacharya
Tanishta Bhattacharya
DNDebaleena Nawn
Debaleena Nawn
IJIshana Jha
Ishana Jha
PBPallab Basu
Pallab Basu
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the rapidly evolving RNA virus behind the COVID-19 pandemic, has spawned numerous variants since its 2019 emergence. The multifunctional Nonstructural protein 14 (NSP14) enzyme, possessing exonuclease and messenger RNA (mRNA) capping capabilities, serves as a key player. Notably, single and co-occurring mutations within NSP14 significantly influence replication fidelity and drive variant diversification. This study comprehensively examines 120 co-mutations, 68 unique mutations, and 160 conserved residues across NSP14 homologs, shedding light on their implications for phylogenetic patterns, pathogenicity, and residue interactions. Quantitative physicochemical analysis categorizes 3953 NSP14 variants into three clusters, revealing genetic diversity. This research underscoresthe dynamic nature of SARS-CoV-2 evolution, primarily governed by NSP14 mutations. Understanding these genetic dynamics provides valuable insights for therapeutic and vaccine development.
1

7 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Alaa A. A. AljabaliAlaa A. A. Aljabali
Alaa A. A. Aljabali
Kenneth LundstromKenneth Lundstrom
Kenneth Lundstrom
Altijana Hromic-JahjefendicAltijana Hromic-Jahjefendic
Altijana Hromic-Jahjefendic
Nawal Abd EL-BakyNawal Abd EL-Baky
Nawal Abd EL-Baky
DNDebaleena Nawn
Debaleena Nawn
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
The XEC strain of SARS-CoV-2 has drawn particular attention because of its ability to outcompete existing Omicron strains. Defined by distinctive spike protein mutations, T22N and Q493E, XEC exhibits increased ACE2 binding affinity and partial immune evasion, which may compromise vaccine-induced neutralizing antibodies. Preliminary analyses also indicated that glycosylation changes at the N-terminal domain enhance infectivity and immunological evasion, which may underpin the rising prevalence of XEC. Current evidence does not conclusively associate XEC with greater disease severity, although additional research is required to determine its clinical relevance. Key knowledge gaps include the precise role of recombination events in XEC evolution and the duration of cross-protective T-cell responses. New research priorities include genomic surveillance in under-sampled regions, updated vaccine formulations against novel spike epitopes, and longer-term longitudinal studies to monitor post-acute sequelae. These efforts can be augmented by more computational modeling and the One Health approach that combines human and veterinary sciences. Recent computational findings (GISAID, 2024) point to the potential of XEC for further mutation in under-surveilled reservoirs, enhancing containment challenges and risks. Containing XEC threats will require close coordination among virologists, immunologists, epidemiologists, clinicians, and policymakers, who must adopt proactive strategies in concert to limit viral transmission and safeguard global public health.